Myriad Genetics (MYGN) Intangibles (2010 - 2026)

Myriad Genetics (MYGN) has 17 years of Intangibles data on file, last reported at $145.7 million in Q1 2026.

• Intangibles for Q1 2026 came in at $145.7 million, down 43.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.7 million (down 43.42% YoY), and the FY2025 annual result was $153.4 million, down 41.54% from the prior year.
• Intangibles slipped to $145.7 million in Q1 2026 per MYGN's latest filing, from $153.4 million in the prior quarter.
• Over five years, Intangibles peaked at $393.6 million in Q1 2022 and troughed at $145.7 million in Q1 2026.
• A 5-year average of $299.2 million and a median of $340.9 million in 2024 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2025: Intangibles slipped 3.83% in 2023, then slumped 47.81% in 2025.
• A 5-year view of Intangibles shows it stood at $379.7 million in 2022, then decreased by 7.95% to $349.5 million in 2023, then fell by 24.92% to $262.4 million in 2024, then sank by 41.54% to $153.4 million in 2025, then retreated by 5.02% to $145.7 million in 2026.
• Business Quant data shows MYGN's Intangibles at $145.7 million in Q1 2026, $153.4 million in Q4 2025, and $163.1 million in Q3 2025.